Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06941389
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Children's of Alabama (MRD-HCT) Birmingham, Alabama, United States
- Children's of Alabama (NT-DMT) Birmingham, Alabama, United States
- Nemours Children's Hospital, Delaware (MRD-HCT) Wilmington, Delaware, United States
- Children's National Hospital (MRD-HCT) Washington D.C., District of Columbia, United States
NCT06665997
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Recruiting
Sickle Cell Kidney Biorepository
NCT07064174
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +21 more
- Locations
-
- Parkland Memorial Hospital Dallas, Texas, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Not Yet Recruiting
Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis
NCT07682662
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
- Locations
-
- University of Mississippi Medical Center, Pediatric Emergency Department Jackson, Mississippi, United States
Not Yet Recruiting
Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease
NCT07540767
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
- Locations
-
- Connecticut Children's Medical Center Hartford, Connecticut, United States
NCT07532564
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +60 more
- Locations
-
- University of Maryland Medical Center Baltimore, Maryland, United States
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
NCT03474965
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- University of Florida Gainesville, Florida, United States
- Joe DiMaggio Childrens Hospital Hollywood, Florida, United States
NCT03264989
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
- Locations
-
- Novartis Investigative Site Orange, Florida, United States
- Novartis Investigative Site Tampa, Florida, United States
- Childrens Healthcare of Atlanta . Atlanta, Georgia, United States
- Augusta University Georgia Patient Treatment Augusta, Georgia, United States
NCT04053764
- Conditions
- Albuminuria, Anemia, Anemia, Hemolytic, +24 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- University of Illinois Hospital and Health Sciences System . Chicago, Illinois, United States
- Our Lady of the Lake Regional Medic . Baton Rouge, Louisiana, United States
- East Carolina University BrodySchool of Med 3 Greenville, North Carolina, United States
NCT03478917
- Conditions
- Acute Chest Syndrome, Anemia, Anemia, Hemolytic, +15 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Active, Not Recruiting
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
NCT03814746
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
- Locations
-
- Childrens Healthcare of Atlanta Atlanta, Georgia, United States
- Boston Medical Center Boston, Massachusetts, United States
- Levine Cancer Insitute Carolinas Healthcare System Charlotte, North Carolina, United States
- Univ of Tenn Health Sciences Ctr Memphis, Tennessee, United States